Contribution of impaired mobility to patient burden in multiple sclerosis

Current Medical Research and Opinion
Matthew H Sutliff

Abstract

Multiple sclerosis (MS) is frequently diagnosed during a person's most productive years, and because life expectancy for patients with MS approaches that of the general population, MS is associated with a considerable economic burden from medical costs and lost productivity. In addition, there is a substantial negative impact on quality of life (QOL) and activities of daily living (ADL). While change in walking ability often is the most visible sign of MS, and the classic clinical manifestation, few studies have evaluated the relationship between mobility impairment and patient-reported outcomes like ADL and QOL. The purpose of this article is to review the contribution of mobility impairment to patient-reported outcomes in persons with MS. Searches of PubMed were performed to identify studies from the MS literature, from January 1980 through November 2008, that evaluated the contribution of mobility to the patient burden of disease. Abstracts identified using the search terms 'multiple sclerosis AND (walking OR mobility)' in combination with the terms 'burden,' 'costs,' 'quality of life,' 'activities of daily living,' 'independence,' and 'productivity' were reviewed for relevancy for inclusion. Although impaired mobility is mo...Continue Reading

References

May 1, 1992·Neurology·A D SadovnickD W Paty
Jan 1, 1986·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·A B KornblithH M Baum
Oct 15, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·N MurphyJ L Mérot
Dec 5, 1998·Multiple Sclerosis : Clinical and Laboratory Research·K Whetten-GoldsteinE D Kulas
Dec 22, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·K J Smith, W I McDonald
May 4, 2001·Brain : a Journal of Neurology·J HobartA Thompson
Jan 26, 2002·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·A Solari, D Radice
Oct 3, 2002·Multiple Sclerosis : Clinical and Laboratory Research·R A RudickS Reingold
Dec 11, 2003·Multiple Sclerosis : Clinical and Laboratory Research·Reza VazirinejadChristopher D Ward
Feb 6, 2004·Multiple Sclerosis : Clinical and Laboratory Research·A RiaziJ C Hobart
Feb 7, 2004·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Marcia Finlayson
Sep 16, 2004·QJM : Monthly Journal of the Association of Physicians·L HemmettN Russell
Jul 27, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Robert W MotlErin M Snook
Feb 10, 2006·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Ariel Miller, Sara Dishon
May 13, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·G KobeltB Jönsson
Nov 8, 2006·Multiple Sclerosis : Clinical and Laboratory Research·K GottbergL Widén Holmqvist
Nov 8, 2006·Multiple Sclerosis : Clinical and Laboratory Research·C L MartinM P Galea
Feb 21, 2007·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Gisela KobeltBengt Jönsson
Apr 3, 2007·Journal of Neurology·Sverker JohanssonLena von Koch
Apr 6, 2007·Neurorehabilitation and Neural Repair·D KosS Ilsbroukx
Jun 30, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Wilma M HopmanDonald G Brunet
Oct 19, 2007·Multiple Sclerosis : Clinical and Laboratory Research·Myla D GoldmanJeffrey A Cohen
Dec 7, 2007·Journal of the Neurological Sciences·Robert W Motl, Erin M Snook
Jan 9, 2008·Health and Quality of Life Outcomes·C Allyson JonesKenneth G Warren
Feb 21, 2008·Research in Nursing & Health·Robert W MotlRandall T Schapiro
Mar 19, 2008·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Robert W Motl, Erin M Snook
May 29, 2008·Multiple Sclerosis : Clinical and Laboratory Research·C HeesenS M Gold
Aug 5, 2008·Journal of Neurology·Laura J JulianDavid C Mohr
Aug 23, 2008·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Robert W MotlRachael C Gliottoni

❮ Previous
Next ❯

Citations

Mar 5, 2011·Journal of Neurology·Michaela CoenenUNKNOWN Members of the Consensus Conference
Oct 20, 2011·Journal of Neurology·Bianca Weinstock-GuttmanChristophe Hotermans
Apr 6, 2011·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Andreas A ArgyriouNicolaos Makris
Nov 28, 2012·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Andrew D Goodman, Robert Thompson Stone
May 17, 2011·Neuropsychiatric Disease and Treatment·Keith C Hayes
Jun 8, 2014·BMC Neurology·Sofia StraudiNino Basaglia
Mar 21, 2012·Scandinavian Journal of Occupational Therapy·Andrea ConradAlarcos Cieza
Jun 19, 2012·Expert Opinion on Drug Safety·Sheryl R HautAaron Miller
May 8, 2014·Current Medical Research and Opinion·Christine G KohnDiana M Sobieraj
Jun 29, 2012·Revue neurologique·C Donzé, J De Sèze
Feb 8, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L RachedM Daudon
Dec 15, 2015·International Journal of MS Care·Cecilie FjeldstadGabriel Pardo
Aug 27, 2014·Annals of the New York Academy of Sciences·Andrew R BlightRon Cohen
Oct 19, 2010·Expert Review of Pharmacoeconomics & Outcomes Research·Joshua T Cohen
Nov 1, 2012·Archives of Physical Medicine and Rehabilitation·Victor W MarkMary H Bowman
Mar 20, 2015·Multiple Sclerosis and Related Disorders·Evanthia BernitsasOmar Khan
Jun 28, 2016·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Matthew M EngelhardMyla D Goldman
Aug 16, 2011·Chronic Illness·Michaela CoenenAlarcos Cieza
Oct 11, 2011·Multiple Sclerosis : Clinical and Laboratory Research·Marie KierkegaardLotta Widén Holmqvist
Mar 27, 2013·Multiple Sclerosis : Clinical and Laboratory Research·Jennifer FreemanJohn Zajicek
Apr 30, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Raymond HuppertsJacob Elkins
Oct 9, 2015·Multiple Sclerosis : Clinical and Laboratory Research·Richard MacdonellPer Soelberg Sørensen
Feb 14, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Lidwine Brigitta MokkinkBernard Mj Uitdehaag
Jan 19, 2011·Arquivos de neuro-psiquiatria·Yára Dadalti FragosoWesley Soares Cruz
Jun 8, 2017·Neurorehabilitation and Neural Repair·Kayla McGowanDaniel S Marigold
Sep 12, 2014·Multiple Sclerosis : Clinical and Laboratory Research·M KehoeS Coote
May 14, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Christian MeyerLinard Filli
Apr 1, 2011·International Journal of MS Care·Francois Bethoux, Susan Bennett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.